Invention Grant
- Patent Title: MiR-127 agents for use in the treatment of renal fibrosis
-
Application No.: US16326058Application Date: 2017-08-09
-
Publication No.: US10907156B2Publication Date: 2021-02-02
- Inventor: Laura García Bermejo , Elisa Conde Moreno , Sara Gimenez Moyano , Laura Martín Gómez
- Applicant: FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
- Applicant Address: ES Madrid
- Assignee: FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
- Current Assignee: FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL
- Current Assignee Address: ES Madrid
- Agency: Seed Intellectual Property
- Priority: EP16382399 20160819
- International Application: PCT/EP2017/070223 WO 20170809
- International Announcement: WO2018/033454 WO 20180222
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/713 ; A61K9/00 ; A61K9/127 ; A61K35/761
Abstract:
The present invention provides, among other things, methods and compositions for the effective prophylactical or therapeutical treatment of Chronic kidney disease (CKD), particularly for the prophylactical or therapeutical treatment of the tubulointerstitial fibrosis associated to CKD, more particularly for the prophylactical or therapeutical treatment of renal fibrosis.
Public/Granted literature
- US20190177728A1 MIR-127 AGENTS FOR USE IN THE TREATMENT OF RENAL FIBROSIS Public/Granted day:2019-06-13
Information query
IPC分类:
